Non Nucleoide Reverse Transcriptase Inhibitors (nNRTIs)


Effects of Efavirenz- and Atazanavir-based Regimens on HDL Cholesterol - 8/29/06

Comparison of NRTI-, NNRTI, and PI-sparing Regimens for First-line Therapy - 8/25/06

Four Drugs No Better than Three for First-line Efavirenz-Based Therapy  - 8/22/06

48-week Data on TMC 125, a Next Generation Experimental NNRTI from Tibotec Pharmaceuticals   - 8/18/06

Does Optimal Timing of HAART Initiation Differ with Newer Treatment Regimens That Include Efavirenz or Ritonavir-boosted Protease Inhibitors?   - 8/18/06